Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Reshape Lifesciences Q2 EPS $(2.25) Up From $(87.00) YoY, Sales $1.242M Down From $1.965M YoY

Author: Benzinga Newsdesk | August 14, 2025 05:23pm
Reshape Lifesciences (NASDAQ:RSLS) reported quarterly losses of $(2.25) per share. This is a 97.41 percent increase over losses of $(87.00) per share from the same period last year. The company reported $1.242 million in sales this quarter. This is a 36.79 percent decrease over sales of $1.965 million the same period last year.

Posted In: RSLS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist